MYLAN-RABEPRAZOLE
MYLAN-RABEPRAZOLE
Discontinued
DIN Number
02408392
Drug Class
Human
Market Date
Jul 10, 2013
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02408392
AIG Number0143681001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A02BC04 RABEPRAZOLE
Product Specifications
Dosage FormTablet (Delayed-Release)
Route of AdministrationOral
AHFS Classification56:28.36
Health Canada Classification
ACTIVE INGREDIENTS (1)
RABEPRAZOLE SODIUMActive
Strength: 10 MG
Monograph: RABEPRAZOLE SODIUM